MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06583cam a22005778i 4500 |
| 001 - |
|---|
| control field |
9781003054894 |
| 003 - |
|---|
| control field |
FlBoTFG |
| 005 - |
|---|
| control field |
20211012162527.0 |
| 006 - |
|---|
| fixed length control field |
m o d |
| 007 - |
|---|
| fixed length control field |
cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
201020s2021 onc ob 001 0 eng |
| 040 ## - |
|---|
| -- |
OCoLC-P |
| -- |
eng |
| -- |
rda |
| -- |
OCoLC-P |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781003054894 |
| Qualifying information |
(PDF) |
|
|---|
| International Standard Book Number |
1003054897 |
|
|---|
| International Standard Book Number |
9781000088847 |
| Qualifying information |
(ePub ebook) |
|
|---|
| International Standard Book Number |
1000088847 |
|
|---|
| International Standard Book Number |
9781000088762 |
| Qualifying information |
(PDF ebook) |
|
|---|
| International Standard Book Number |
1000088766 |
|
|---|
| International Standard Book Number |
9781000088809 |
| Qualifying information |
(Mobipocket ebook) |
|
|---|
| International Standard Book Number |
1000088804 |
|
|---|
| -- |
9781771889247 |
| Qualifying information |
(hardcover) |
| 024 8# - |
|---|
| -- |
10.1201/9781003054894 |
| -- |
doi |
| 035 ## - |
|---|
| -- |
(OCoLC)1200842589 |
|
|---|
| -- |
(OCoLC-P)1200842589 |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| -- |
RM301.25 |
| 072 #7 - |
|---|
| -- |
MED |
| -- |
004000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
060000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
071000 |
| -- |
bisacsh |
|
|---|
| -- |
VXH |
| -- |
bicssc |
| 082 0# - |
|---|
| Classification number |
615.1/9 |
| -- |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Applied pharmaceutical practice and nutraceuticals : |
| Remainder of title |
natural product developments / |
| Statement of responsibility, etc |
edited by Debarshi Kar Mahapatra, PhD, Cristóbal Noé Aguilar, PhD, A.K. Haghi, PhD. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. |
| 505 0# - |
|---|
| Formatted contents note |
Chalcone (1,3-Diphenyl-2-Propene-1-One) Scaffold Bearing Natural Compounds as Nitric Oxide Inhibitors: Promising Antiedema Agents / Debarshi Kar Mahapatra, Sanjay Kumar Bharti, and Vivek Asati -- Emblicanin-A and Emblicanin-B: Pharmacological and Nano-Pharmacotherapeutic Perspective for Healthcare Applications / Mohamad Taleuzzaman, Debarshi Kar Mahapatra, and Dipak Kumar Gupta -- Recent In-Depth Insights of Nature-Based Anti-Worm Therapeutic Medications: Emerging Herbal Anthelmintics / Ankita Soni, Paras Kothari, and Debarshi Kar Mahapatra -- Insights into the Recent Scientific Evidences of Natural Therapeutic Treasures as Diuretic Agents / Vaibhav Shende, Sameer Hedaoo, and Debarshi Kar Mahapatra -- Reviewing the Available Herbal Resources for Treating Psoriasis: Safe and Alternative Way for Therapeutics / Shruti Dongare, Vaibhav Shende, and Debarshi Kar Mahapatra -- Nutraceuticals and Brain Disorders / Akshada Atul Bakliwal, Vijay Sharadkumar Chudiwal, and Swati Gokul Talele -- 1,3-Diphenyl-2-Propene-1-One-Based Natural Product Antidiabetic Molecules as Inhibitors of Protein Tyrosine Phosphatase-1B (PTP-1B) / Debarshi Kar Mahapatra, Sanjay Kumar Bharti, and Vivek Asati -- Re-Highlighting the Potential Natural Resources for Treating or Managing the Ailments of Gastrointestinal Tract Origin / Vaibhav Shende, Sameer A. Hedaoo, Mojabir Hussen Ansari, Pooja Bhomle, and Debarshi Kar Mahapatra -- Recent Advancements of Curcumin Analogs and Curcumin Formulations in Context to Modern Pharmacotherapeutics Perspectives / Animeshchandra G. M. Haldar, Kanhaiya M. Dadure, and Debarshi Kar Mahapatra -- Emerging Highlights on Natural Prodrug Molecules with Multifarious Therapeutic Perspectives / Mojabir Hussen Ansari, Vaibhav Shende, and Debarshi Kar Mahapatra -- Perspectives of Nature-Oriented Pharmacotherapeutics for the Effectual Management of Hemorrhoidal Symptoms / Taranpreet Kaur Bamrah, Mojabir Hussen Ansari, and Debarshi Kar Mahapatra -- Effect of Light on Transport of Potassium Thiocyanate in Aqueous Solutions / Sónia I. G. Fangaia, Pedro M. G. Nicolau, Fernando A. D. R. A. Guerra,V. M. M. Lobo, and Ana C. F. Ribeiro -- Drug Discovery, Drug-Likeness Screening, and Bioavailability: Development of Drug-Likeness Rule for Natural Products / E. D Ahire, V. N. Sonawane, K. R. Surana, and G. S.Talele -- Biomolecular and Molecular Docking: A Modern Tool in Drug Discovery and Virtual Screening of Natural Products / Khemchand R. Surana, Eknath D. Ahire, Vijayraj N. Sonawane, and Swati G. Talele. |
| 650 #0 - |
|---|
| Topical term or geographic name as entry element |
Drug development. |
|
|---|
| Topical term or geographic name as entry element |
Natural products. |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Alternative Medicine |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Nutrition |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Pharmacology |
| 700 1# - |
|---|
| Personal name |
Mahapatra, Debarshi Kar, |
| Relator term |
editor. |
|
|---|
| Personal name |
Aguilar, Cristóbal Noé, |
| Relator term |
editor. |
|
|---|
| Personal name |
Haghi, A. K., |
| Relator term |
editor. |
| 856 40 - |
|---|
| Uniform Resource Identifier |
https://www.taylorfrancis.com/books/9781003054894 |
|
|---|
| Uniform Resource Identifier |
http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
| 264 #1 - |
|---|
| -- |
Palm Bay, FL, USA ; |
| -- |
Burlington, ON, Canada : |
| -- |
Apple Academic Press ; |
| -- |
Boca Raton, FL, USA ; |
| -- |
Abingdon, Oxon, UK : |
| -- |
CRC Press , |
| -- |
2021. |
| 336 ## - |
|---|
| -- |
text |
| -- |
txt |
| -- |
rdacontent |
| 337 ## - |
|---|
| -- |
computer |
| -- |
c |
| -- |
rdamedia |
| 338 ## - |
|---|
| -- |
online resource |
| -- |
cr |
| -- |
rdacarrier |
| 520 ## - |
|---|
| -- |
"Applied Pharmaceutical Practice and Nutraceuticals: Natural Product Developments showcases how pharmaceutical and nutraceutical compounds from natural products can be used to cure or prevent diseases. The chapters explore the connections between agrochemicals and pharmaceuticals and the use of plants and plant products in the formulation and development of new pharmaceuticals and nutraceuticals. The pharmaceutical industry recognizes the shift to the use of natural products while also considering the serious concerns that have arisen regarding the claimed efficacy, quality, and safety of these products. Chapters cover: The emerging perspectives of natural chalcone-based nitric acid inhibitors, the pharmacological properties of Emblicanin-A and Emblicanin-B constituents found in Phyllanthus emblica, the pathophysiology and various herbal drugs used for treating helminthiasis (or worm infections) and their pharmacological activities, natural medicines that can be employed as diuretics, the utilization, safety, and therapeutic perspectives of medicinal plant for treating psoriasis and skin diseases, the role of nutrients and cofactors, dietary adjustments and gut anomalies, probiotics and prebiotics, phytochemicals, and ecological factors for evaluating the condition of proof in nutraceutical-based disease management practices, beer as a major source of compounds associated with health benefits, which could possibly decrease the risks of cardiovascular disease, the role of the media as an important source of health information to help with personal medical decisions, specifically regarding cancer, the composition of Artemisia herba-alba and Origanum majorana essential oils is analyzed, and their antibacterial and antifungal activity, how medicinal plants and herbs combined with some kinds of alcohol develop healing, stimulating, and aphrodisiac effects while others can cause adverse effects and allergies."-- |
| -- |
Provided by publisher. |
| 588 ## - |
|---|
| -- |
OCLC-licensed vendor bibliographic record. |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
| 856 40 - |
|---|
| -- |
Taylor & Francis |
|
|---|
| -- |
OCLC metadata license agreement |
